When AB-rated generic versions of brand-name drugs are available, the choice is up to you
 |
The Food & Drug Administration (FDA) has determined that approved AB-rated generics are bioequivalent and therapeutically equivalent to brand-name drugs1 |
Substitutions may be made at the pharmacy without your knowledge2
|
Pharmacists may have the ability to change your prescription to an AB-rated generic without consulting you or the patient |
|
|
Some states have mandated that the pharmacist fill a prescription with the least expensive available drug |
|
In other states, substitution is not mandatory, but the pharmacist can still substitute a brand-name antiepileptic drug with a generic at his or her discretion |
|
|
Managed care organizations often encourage generic substitutions |
"FDA evaluation of therapeutic equivalence in no way relieves practitioners of their professional responsibilities in prescribing and dispensing such products with due care and with appropriate information to individual patients."1
As the prescribing physician, you know what is best for your patients
Indicate "Dispense as Written" when your choice is brand-name TRILEPTAL
|
With the availability of generics: |
|
|
The only way to ensure that your patients receive TRILEPTAL when the goal is control of their partial seizures |
|
The only way to protect the integrity of your choice for TRILEPTAL |
|
Ask your patients to make sure that they receive the TRILEPTAL you prescribed
|
Patients may be unaware that generic oxcarbazepine may be substituted for their TRILEPTAL prescription without their knowledge |
|
Checking the label to make sure they have received TRILEPTAL before they leave the pharmacy will ensure they get the TRILEPTAL you have prescribed |
| For additional information on how to protect your choice, please visit the Resource Center. |
References:
|
|
E-mail this page